NCT03826615View on ClinicalTrials.gov

Gabapentin Pretreatment for Staged Bilateral Cataract Operations

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

January 3, 2020

Study Completion Date

January 3, 2020

Conditions
HyperalgesiaCataract Bilateral Nos
Interventions
DRUG

Gabapentin

Patients receive gabapentin 100mg orally for 3 times a day during the period of first and second cataract operations

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT03826615 - Gabapentin Pretreatment for Staged Bilateral Cataract Operations | Biotech Hunter | Biotech Hunter